Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik De Keyzer

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Plos One|July 21, 2012
Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRIFeng Chen, Yingmei Feng, Kaier Zheng, et al.
European Urology Focus|July 30, 2017
Rationale for Modernising Imaging in Advanced Prostate CancerAnwar R Padhani, Frederic E Lecouvet, Nina Tunariu, et al.
European Urology|June 19, 2016
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate CancerAnwar R Padhani, Frederic E Lecouvet, Nina Tunariu, et al.
Neuro-Oncology|January 29, 2014
Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomasSofie Van Cauter, Frederik De Keyzer, Diana M Sima, et al.
Translational Oncology|December 7, 2019
Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRIYewei Liu, Qiu Guan, Xiangyong Kong, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Plos One|July 21, 2012
Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRIFeng Chen, Yingmei Feng, Kaier Zheng, et al.
European Urology Focus|July 30, 2017
Rationale for Modernising Imaging in Advanced Prostate CancerAnwar R Padhani, Frederic E Lecouvet, Nina Tunariu, et al.
European Urology|June 19, 2016
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate CancerAnwar R Padhani, Frederic E Lecouvet, Nina Tunariu, et al.
Neuro-Oncology|January 29, 2014
Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomasSofie Van Cauter, Frederik De Keyzer, Diana M Sima, et al.
Translational Oncology|December 7, 2019
Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRIYewei Liu, Qiu Guan, Xiangyong Kong, et al.
Pageof 11